Glyceraldehyde (GLA) was determined in glucose degradation and glycation. GLA was detected as a decahydroacridine-1,8-dione derivative on reversed phase HPLC using cyclohexane-1,3-dione derivatizing reagent. The glucose-derived GLA level was higher than the glycation-derived GLA level, because GLA was converted to intermediates and advanced glycation end products (AGE) in glycation. GLA was also generated from 3-deoxyglucosone and glucosone as intermediates of glucose degradation and glycation. This study suggests that glyceraldehyde is generated by hyperglycemia in diabetes, and that it is also formed in medicines such as peritoneal dialysis solution.
Recent studies suggest that glyceraldehyde-modified protein affects cell function. GLA-modified albumin shows cytotoxicity in rat primary cultured cortical neurons 3) and Schwann cells. 4) In addition, GLA-modified albumin induces apoptosis and expression of vascular endothelial growth factor (VEGF) in bovine retinal pericytes, 5) and also induces apoptosis and expression of VEGF and monocyte chemoattractant protein-1 (MCP-1) in human mesangial cells. 6) We have reported that GLA-derived advanced glycation end product (AGE) induces oxidative stress. 7, 8) Moreover, GLA-modified protein is detected by an immunological technique in the Alzheimer's disease specimens. 9) GLA and GLA-derived AGE are generated in some diseases, and can cause the pathological changes and physiological effects. GLA is perhaps increased by reduced activity of GLA-related enzymes, such as glyceraldehyde-3-phosphate dehydrogenase (GAPDH). In addition, GLA might be generated by glucose degradation and the glycation.
In this study, GLA, generated in glucose degradation and glycation, was determined to be a decahydroacridine-1,8-dione derivative by reversed phase HPLC by simple derivatization using cyclohexane-1,3-dione.
Materials and Methods
Chemicals. Glyceraldehyde and glucose were obtained from Sigma-Aldrich (St. Louis, MO). Cyclohexane-1,3-dione and benzoylhydrazine were from Tokyo Chemical Industry (Tokyo). Benzaldehyde, acetic acid, and methanol (HPLC grade) were from Kanto Chemical (Tokyo). Glycine, lysine, p-toluidine, and 2,4-dinitrophenylhydrazine were from Wako Pure Chemical (Osaka, Japan). All other chemicals used in this study were of analytical reagent grade. Water was used after purification by reverse osmosis, using Milli RO 10PLUS (Millipore, Billerica, MA), and further treated with Simpli Lab-UV (Millipore).
Synthesis of 3-deoxyglucosone. 3-Deoxyglucosone (3DG) was synthesized according to the method described by Kato et al.
10) D-glucose (16 g) and p-toluidine (8.8 g) were refluxed in a mixture of 95% ethanol (360 ml) and acetic acid (17.6 ml) at 110 C for 30 min. Then benzoylhydrazine (26.4 g) was added to the soly To whom correspondence should be addressed. Fax: +81-44-934-7902; E-mail: fumi@isc.meiji.ac.jp Abbreviations: AGE, advanced glycation end products; ANOVA, one factor analysis of variance; CAPD, continuous ambulatory peritoneal dialysis; 1,3CHD, cyclohexane-1,3-dione; DA, dihydroxyacetone; 3DG, 3-deoxyglucosone; DNP, 2,4-dinitrophenylhydrazine; GLA, glyceraldehyde; GLUCO, glucosone; MCP-1, monocyte chemoattractant protein-1; MGO, methylglyoxal; PDA, photo diode array; TR, triose reductone; TRIO, triosone; VEGF, vascular endothelial growth factor ution and refluxed at 110 C for 7 h. The mixture was cooled at room temperature and kept at 4 C for 18 h. It was filtered, and the residue was washed with diethylether (3 Â 100 ml) and ethanol (3 Â 100 ml). The residue was obtained as 3-deoxyglucosone-bis-benzoylhydrazone (3DG-bis).
3DG-bis (6.5 g) and distilled benzaldehyde (10.2 ml) were refluxed in a mixture of 99.5% ethanol (200 ml), 300 ml of water, and acetic acid (7.6 ml) at 110 C for 4.5 h. The mixture was cooled to room temperature, and water (50 ml) to the solution.
The solution was evaporated to 80 ml. The concentrate was cooled to 2 C overnight. The solution was filtered, and the filtrate was washed with ether (20 Â 50 ml). The aqueous layer was put on an Amberlite IR-120(H þ ) (Rohm and Haas, Philadelphia, PA) column and fractionated. The fractions containing 3DG were detected with DNP reagent (0.4% 2,4-dinitrophenylhydrazine in 2 N HCl). The fractions including 3DG were lyophilized as crude-3DG.
Crude-3DG was dissolved in a small amount of solvent as ethylacetate-methanol-water (6:1:1). The solution was put on a silica gel 60 (Merck, Darmstadt, Germany) column equilibrated with the same solvent. 3DG was monitored by TLC with DNP reagent, and fractions containing 3DG were concentrated under reduced pressure. The residue was further purified by silica gel chromatography in the same manner. Finally the residue was dissolved in water, and the solution was lyophilized as 3DG.
Synthesis of glucosone. D-Glucosone (GLUCO) was synthesized according to the method of Bayne.
11) DGlucose (25 g) was dissolved in a mixture of water (100 ml) and acetic acid (32.5 ml) at 80 C. Phenylhydrazine (65 ml) was added to the mixture, which was stirred at 80 C for 2 h. The reaction mixture was mixed with 1,600 ml of water and kept at 2 C for 2 h. Then it was filtered, and the residue was washed with 10% acetic acid (2 Â 100 ml) and water (4 Â 100 ml). Yellow residue was dissolved in hot 50% pyridine and kept at 2 C for 24 h. The residue was obtained by filtration and washed with cold ethanol (3 Â 25 ml). The yellow needle crystal was obtained as D-arabino-hexose phenylosazone.
D-Arabino-hexose phenylosazone (6.5 g) and distilled benzaldehyde (10.2 ml) were dissolved in ethanol (200 ml), and a mixture of water (300 ml) and acetic acid (7.6 ml) was added. The reaction mixture was refluxed at 110 C for 4.5 h and then cooled to room temperature. It was mixed with water (50 ml) and concentrated to 100 ml under reduced pressure. The concentrate was cooled to 2 C overnight. The solution was filtered, and the filtrate was washed with ether (20 Â 50 ml). The aqueous layer was put on an Amberlite IR-120(H þ ) column and fractionated. The fractions containing GLUCO were detected with DNP reagent. The fractions including GLUCO were lyophilized as crude GLUCO.
Crude GLUCO was dissolved in a small amount of the solvent as ethylacetate-methanol-water (6:1:1). The solution was put on a silica gel column (50 Â 5 cm I.D.) equilibrated with the same solvent. GLUCO was monitored by TLC with DNP reagent, and fractions containing GLUCO were concentrated under reduced pressure. The residue was further purified by silica gel chromatography in the same manner. Finally the residue was dissolved in water, and the solution was lyophilized as GLUCO. HPLC analysis. The derivative procedure was performed by the method of Suzuki.
12) Briefly, cyclohexane-1,3-dione (0.25 g) was dissolved in a mixture consisting of ammonium acetate (10 g), acetic acid (5 ml), and water (50 ml), and the solution was used as a derivatizing reagent. A sample solution (0.5 ml) was mixed with an equal volume of derivatizing reagent and incubated at 60 C for 30 min. The mixture was filtered with a hydrophilic LCR (PTFE) membrane filter unit (Millex-LH, Millipore), and then 5 ml of the sample was put on a Puresil C 18 column (150 Â 4:6 mm I.D., Waters, Milford, MA) on preparative reversed phase HPLC. The sample was eluted with a linear gradient of 10-90% methanol from 0 to 20 min at a flow rate of 1 ml/min. Glyceraldehyde derivative was detected with absorbance at 370 nm using a Photo Diode Array (PDA) detector and a fluorescence detector (Ex. 366 nm/Em. 440 nm).
Apparatus. The Alliance HPLC System (Waters) consisted of pump 1525, a 2996 Photo Diode Array (PDA) detector, a 2475 fluorescence detector, a 717 auto sampler, and an AF in-line degasser. Data were calculated by the Empower microcomputer program (Waters).
Statistical analysis. Numerical data were expressed as the means AE SD (n ¼ 3). Statistical significance of differences was established by one-way analysis of variance (ANOVA), Dunnett's test, and Student's t test by the JMP 4.0.5J microcomputer program (SAS Institute, Cary, NC). Differences with probability values of less than 5% were considered significant.
Result and Discussion
Glyceraldehyde (GLA) was determined to be decahydroacridine-1,8-dione derivative by reversed phase HPLC. 1,3CHD was used as a derivatizing reagent. The reaction scheme is shown in Fig. 1 . The method has been applied for analysis of aliphatic aldehydes, as based on Hantzsch's dehydropyridine synthesis. 12, 13) Briefly, enamine was generated from cyclohexane-1,3-dione with ammonium, and an Aldol condensation product was formed from cyclohexane-1,3-dione with GLA. The alpha,beta-unsaturated carbonyl of enamine was adducted to the Aldol condensation product in the Michael reaction. The amino residue was adducted to the carbon of carbonyl and cyclized by dehydration. Finally, decahydroacridine-1,8-dione derivative was produced by this derivative procedure. In this study, 9-(1,2-dihydroxy-ethyl)-3,4,6,7,9,10-hexahydro-2H,5H-acridine-1,8-dione was formed as a derivative of GLA.
The visible spectrum of the product showed a maximum peak at 370 nm. Figure 1B shows the typical elution profile of the GLA derivative on reversed phase HPLC using a photo diode array (PDA) detector (absorbance at 370 nm). A single peak was detected as a GLA derivative (the peak with arrow). Figure 1C and D show a typical elution profile of the GLA derivative (Fig. 1C) and a derivative reagent (Fig. 1D ) on highly the sensitive fluorescence detection (Ex. 366 nm, Em. 440 nm). Fluorescence detection showed several peaks from the derivatizing reagent, as shown in Fig. 1C . The regression line is shown in Fig. 1E (A 370 nm) and F (fluorescence).
Subsequently, glucose solutions (50 mM and 200 mM) were incubated at 37 C or 50 C, and the GLA level was determined by the pre-labeled fluorescence HPLC method. As shown in Fig. 2 , GLA was generated from glucose. The formation of GLA was dose-dependent and temperature-dependent on the glucose degradation. In the derivative reaction, the reagent did not react with glucose, and no glyceraldehyde derivative was found from glucose.
Furthermore, GLA was detected in glycation. GLA was formed from glucose with lysine or glucose with glycine in the glycation process, as shown in Fig. 3 . Glycine was used as a typical alpha amino acid, and lysine was used as a reactive amino acid in glycation. The GLA level was lower than the glucose degradation. In this case, GLA might have been converted to an intermediate and AGE in GLA-related glycation.
Additionally, GLA was also formed from 3-deoxyglucosone (3DG) and glucosone (GLUCO), intermediates of glucose degradation and glycation (Fig. 4) . 3DG and GLUCO were the intermediates of GLA formation, but peak separation was not very good.
The proposed pathway of GLA formed from glucose is shown in Fig. 5 . It is known that GLA is generated from glucose by the retro-Aldol reaction. In addition, GLA and methylglyoxal are formed from 3DG, and GLA and triosone are formed from GLUCO by the retro-Aldol reaction. Through these pathways, GLA might be formed from glucose in the organism and the food system.
In hyperglycemia due to diabetes, GLA might be generated from glyceraldehyde-3 phosphate which is increased by reduced activity of enzymes, such as glyceraldehyde-3 phosphate dehydrogenase, and glucose-derived carbonyls, such as 3-deoxyglucosone and glucosone. Moreover, GLA might be increased in continuous ambulatory peritoneal dialysis (CAPD) therapy. CAPD is a typical blood purification technique in chronic renal failure, and a peritoneal dialysis solution is injected into the peritoneal cavity in this therapy. The conventional peritoneal dialysis solutions include glucose (approximately, 1.5-4.25%). GLA is probably produced by the infusion of peritoneal dialysis solution.
In this study, we determined that GLA is formed in the degradation of glucose and glycation. GLA formation might figure in the progression of diabetic complications.
